Search

Type 2 diabetes is associated with raised risk of several cancers, but for type 1 diabetes risk data are fewer and inconsistent We assembled a cohort of 23 473 UK patients with insulin‐treated diabetes diagnosed at ages <30, almost all of whom will have had type 1 diabetes, and for comparison 5058 diagnosed at ages 30 to 49, of whom we estimate two‐thirds will have had type 2, and followed them for an average of 30 years for cancer incidence and mortality compared with general population rates. Patients aged <30 at diabetes diagnosis had significantly raised risks only for ovarian (standardised incidence ratio = 1.58; 95% confidence interval 1.16‐2.11; P <.01) and vulval (3.55; 1.94‐5.96; P <.001) cancers, with greatest risk when diabetes was diagnosed at ages 10‐14. Risks of cancer overall (0.89; 0.84‐0.95; P <.001) and sites including lung and larynx were significantly diminished. Patients diagnosed with diabetes at ages 30 to 49 had significantly raised risks of liver (1.76;1.08‐2.72) and kidney (1.46;1.03‐2.00) cancers, and reduced risk of cancer overall (0.89; 0.84‐0.95). The raised ovarian and vulval cancer risks in patients with type 1 diabetes, especially with diabetes diagnosed around pubertal ages, suggest possible susceptibility of these organs at puberty to metabolic disruption at diabetes onset. Reduced risk of cancer overall, particularly smoking and alcohol‐related sites, might reflect adoption of a healthy lifestyle. [ABSTRACT FROM AUTHOR]

Aims: To describe type 1 diabetes incidence in Scotland between 2006 and 2019. Methods: Repeated annual cross‐sectional studies of type 1 diabetes incidence were conducted. Incident cases were identified from the Scottish Care Information—Diabetes Collaboration (SCI‐DC), a population‐based register of people with diagnosed diabetes derived from primary and secondary care data. Mid‐year population estimates for Scotland were used as the denominator to calculate annual incidence with stratification by age and sex. Joinpoint regression was used to investigate whether incidence changed during the study period. Age and sex‐specific type 1 diabetes incidence over the whole time period was estimated by quintile of the Scottish Index of Multiple Deprivation (SIMD), an area‐based measure, in which Q1 and Q5 denote the most and least deprived fifths of the population, respectively, with quasi‐Poisson regression used to compare incidence for Q5 compared to Q1. Results: The median (IQR) age of the study population of 14,564 individuals with incident type 1 diabetes was 24.1 (12.3–42.4) years, 56% were men, 23% were in Q1 and 16% were in Q5. Incidence of T1DM was higher in men than women overall (at around 22 and 17 per 100,000, respectively) and in under 15 year olds (approximately 40 per 100,000 in both sexes) than other age groups and was similar across the study period in all strata. There was an inverse association between socio‐economic status and type 1 diabetes incidence for 15–29, 30–49 and 50+ year olds [incidence rate ratio (IRR) for Q5 compared to Q1; IRR (95% CI) 0.52 (0.47–0.58), 0.68 (0.61–0.76) and 0.53(0.46–0.61), respectively] but not for under 15 year olds [1.02 (0.92–1.12)]. Conclusion: Incidence of type 1 diabetes varies by age, sex and socio‐economic status and has remained approximately stable from 2006 to 2019 in Scotland. [ABSTRACT FROM AUTHOR]

Aims: Type 1 diabetes is associated with an increased risk of cardiovascular disease and all‐cause mortality. Numerous studies have demonstrated that outcomes for diabetes are improved by intensive glycaemic control, blood pressure control, and treatment of dyslipidaemia in addition to cessation of smoking. The aim of this study was to compare mortalities in individuals with type 1 diabetes with that in non‐diabetic individuals, and to investigate the effects of age, gender, glycaemic control, socio‐economic status, hypertension, ischaemic heart disease (IHD), smoking status, body mass index (BMI) and dyslipidaemia. Methods: A population‐based analysis in Ayrshire and Arran, Scotland included 253 304 non‐diabetic individuals and 1324 individuals with type 1 diabetes who were tracked from 2009 to 2014. Results: Patients with type 1 diabetes had higher mortality rates than non‐diabetic individuals (HR, 3.20; P < .01), with relative mortality in female individuals with type 1 diabetes being higher than that in males (OR, 2.38 vs 1.52; P < .01). Increasing age (HR, 2.37), smoking (HR, 1.85), IHD (HR, 1.62) and hypertension (HR, 1.21) (all P < .01) increased mortality risk. A hypertensive female with type 1 diabetes and IHD who smoked had an HR of 11.6 compared with a non‐smoking, normotensive non‐diabetic female without IHD. For a hypertensive male with type 1 diabetes and IHD who smoked, HR was 6.96. BMI > 30 kg/m2 was associated with reduced mortality risk in both non‐diabetic (HR, 0.61) and diabetic subjects (HR, 0.40). Conclusions: This study confirmed that the risk of mortality in individuals with type 1 diabetes remains elevated. Further studies are required to understand how gender affects the disparity in mortality and why obesity appears to be protective. [ABSTRACT FROM AUTHOR]

Aim and objective: The aim of this study was to describe and explore parents' information and support needs when their child is diagnosed with type 1 diabetes, including their views about the timing and chronology of current support provision. Our objective was to identify ways in which parents could be better supported in the future. Design and participants: Semi ‐ structured interviews were conducted with 54 parents of children with type 1 diabetes in four paediatric diabetes clinics in Scotland. Data were analysed using an inductive, thematic approach. Findings: Parents described needing more reassurance after their child was diagnosed before being given complex information about diabetes management, so they would be better placed psychologically and emotionally to absorb this information. Parents also highlighted a need for more emotional and practical support from health professionals when they first began to implement diabetes regimens at home, tailored to their personal and domestic circumstances. However, some felt unable to ask for help or believed that health professionals were unable to offer empathetic support. Whilst some parents highlighted a need for support delivered by peer parents, others who had received peer support conveyed ambivalent views about the input and advice they had received. Conclusions: Our findings suggest that professionals should consider the timing and chronology of support provision to ensure that parents' emotional and informational needs are addressed when their child is diagnosed and that practical advice and further emotional support are provided thereafter, which takes account of their day ‐ to ‐ day experiences of caring for their child. [ABSTRACT FROM AUTHOR]

Our objective was to perform a pilot study to estimate the proportion of published errata linked to randomized controlled trials (RCTs) that are worthwhile obtaining when doing a systematic review. medline was searched for records that had both ‘randomized-controlled-trial’ in the publication type field and ‘erratum’ in the comments field. One hundred records from four general medical journals were examined independently from two different perspectives. From the information specialist's perspective, 74% of the errata were considered worthwhile obtaining; these were mainly errors in tables or figures. Another 9% described less serious errors, but were worth obtaining if easily available. The other 17% were minor errors. From the perspective of the experienced reviewer/public health consultant, 5% of errata were classified as likely to affect a meta-analysis, and 10% as having significant errors that would affect the interpretation of the RCT, but no effect on a meta-analysis; 85% were not considered important enough to affect either. About 5% of errata to RCTs appeared to matter in terms of changing the final conclusions of a systematic review. However, the majority of errata were considered to be worthwhile obtaining, on the basis that having full and accurate data can reduce confusion and save reviewers time. [ABSTRACT FROM AUTHOR]

Assesses the value of the cervical smear test to women in Scotland. Positive and negative aspects of the cervical screening service; Relation between willingness to pay for a cervical smear test and income of women; Alternative approaches to cervical screening.

LINKED CONTENT This article is linked to Nicholson et al and Turvill papers. To view these articles, visit https://doi.org/10.1111/apt.15969 and https://doi.org/10.1111/apt.16051 and https://doi.org/10.1111/apt.16082 [ABSTRACT FROM AUTHOR]